Back
Arvinas 10K Form
Sell
36
ARVN
Arvinas
Last Price:
24.38
Seasonality Move:
3.51%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-08-04 | 10Q | ARVN/Arvinas Quarterly |
2020-04-28 | 10Q | ARVN/Arvinas Quarterly |
2020-03-16 | 10K | ARVN/Arvinas Annual |
2019-11-04 | 10Q | ARVN/Arvinas Quarterly |
2019-08-05 | 10Q | ARVN/Arvinas Quarterly |
2019-05-09 | 10Q | ARVN/Arvinas Quarterly |
Receive ARVN News And Ratings
See the #1 stock for the next 7 days that we like better than ARVN
ARVN Financial Statistics
Sales & Book Value
Annual Sales: | $78.5M |
---|---|
Cash Flow: | $49.6M |
Price / Cash Flow: | 0 |
Annual Sales: | $8.75 |
Price / Book: | 2.79 |
Profitability
EPS (TTM): | -5.17000 |
---|---|
Net Income (TTM): | $-323.4M |
Gross Margin: | -- |
Return on Equity: | -57.95% |
Return on Assets: | -27.23% |
Arvinas Earnings Forecast
Key Arvinas Financial Ratios
- The Research & Development expenses have been 483.69% of Revenue.
- The Interest Expense is -0.05% of Operating Income.
- The Net Earning history of ARVN is -467.90% of Total Revenues.
- Per Share Earnings over the last 8 years have been positive in 1 years.
Arvinas Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | ARVN |
CUSIP: | 04335A |
Website: | arvinas.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 3.62 |
Quick Ratio: | 3.57 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |